C.86-Breast Cancer And Virus: Molecular Homology Between Human Mammary Tumor Virus 3’Orf And Scorpio

C.86-Breast Cancer And Virus: Molecular Homology Between Human Mammary Tumor [...]

C.86-Breast Cancer And Virus: Molecular Homology Between Human Mammary Tumor Virus 3’Orf And Scorpio2023-10-26T14:29:16+02:00

C.82bis- Therapeutic Protocol defended by the « POSITIFS » Association. Replacement of HAART by a low

C.82bis- Therapeutic Protocol defended by the "POSITIFS" Association. Replacement of [...]

C.82bis- Therapeutic Protocol defended by the « POSITIFS » Association. Replacement of HAART by a low2023-10-26T14:35:51+02:00

C.82- Protocole Thérapeutique de « Positifs ».Remplacement des HAART par un traitement peu toxique

C.82- Protocole Thérapeutique de « Positifs ».Remplacement  des HAART par un traitement peu [...]

C.82- Protocole Thérapeutique de « Positifs ».Remplacement des HAART par un traitement peu toxique2023-10-26T14:37:34+02:00

C.80-AIDS Vaccine Thai RV 144 Correlate of Protection: Envelope gp120 v2 Loop, Which Induces Protect

C.80-AIDS Vaccine Thai RV 144 . Correlate of Protection: Envelope [...]

C.80-AIDS Vaccine Thai RV 144 Correlate of Protection: Envelope gp120 v2 Loop, Which Induces Protect2023-10-26T14:41:42+02:00

C.81-Voltage-gated sodium Na+ channel allostery as the basis for the scorpion venom model of AIDS

C.81-Voltage-gated sodium Na+ channel allostery as the basis for the [...]

C.81-Voltage-gated sodium Na+ channel allostery as the basis for the scorpion venom model of AIDS2023-10-26T14:40:20+02:00

C.79-Hepatitis C virus and type 2 diabetes: Molecular homology between HCV E2 envelope and glucagon

C.79-Hepatitis C virus and type 2 diabetes: Molecular homology between [...]

C.79-Hepatitis C virus and type 2 diabetes: Molecular homology between HCV E2 envelope and glucagon2023-10-26T14:39:01+02:00

C.75 bis. Nouveau traitement efficace, de faible toxicité et de faible coût, utilisant de nouvelle

C.75bis.Nouveau traitement efficace, de faible toxicité et de faible coût, [...]

C.75 bis. Nouveau traitement efficace, de faible toxicité et de faible coût, utilisant de nouvelle2023-10-30T06:49:32+01:00
Aller en haut